NPC1 is enriched in unexplained early onset ataxia: a targeted high-throughput screening
Crossref DOI link: https://doi.org/10.1007/s00415-015-7889-y
Published Online: 2015-09-04
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Synofzik, Matthis
Harmuth, Florian
Stampfer, Miriam
Müller vom Hagen, Jennifer
Schöls, Ludger
Bauer, Peter
Funding for this research was provided by:
Actelion Pharmaceuticals
Text and Data Mining valid from 2015-09-04